BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27729325)

  • 1. Metabolite and Microbiome Interplay in Cancer Immunotherapy.
    Johnson CH; Spilker ME; Goetz L; Peterson SN; Siuzdak G
    Cancer Res; 2016 Nov; 76(21):6146-6152. PubMed ID: 27729325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal Microbiota and Colon Cancer.
    Hold GL
    Dig Dis; 2016; 34(3):244-50. PubMed ID: 27028619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism links bacterial biofilms and colon carcinogenesis.
    Johnson CH; Dejea CM; Edler D; Hoang LT; Santidrian AF; Felding BH; Ivanisevic J; Cho K; Wick EC; Hechenbleikner EM; Uritboonthai W; Goetz L; Casero RA; Pardoll DM; White JR; Patti GJ; Sears CL; Siuzdak G
    Cell Metab; 2015 Jun; 21(6):891-7. PubMed ID: 25959674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
    Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
    Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heightened importance of the microbiome in cancer immunotherapy.
    Villemin C; Six A; Neville BA; Lawley TD; Robinson MJ; Bakdash G
    Trends Immunol; 2023 Jan; 44(1):44-59. PubMed ID: 36464584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota: a key orchestrator of cancer therapy.
    Roy S; Trinchieri G
    Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy.
    Sethi V; Vitiello GA; Saxena D; Miller G; Dudeja V
    Gastroenterology; 2019 May; 156(7):2097-2115.e2. PubMed ID: 30768986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of microbiota, mucosal malignancies, and immunotherapy-Mechanistic insights.
    Mager LF; Krause T; McCoy KD
    Mucosal Immunol; 2024 Jun; 17(3):402-415. PubMed ID: 38521413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
    Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
    Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism.
    Dheer R; Patterson J; Dudash M; Stachler EN; Bibby KJ; Stolz DB; Shiva S; Wang Z; Hazen SL; Barchowsky A; Stolz JF
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):397-408. PubMed ID: 26529668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and the microbiome.
    Gunjur A
    Lancet Oncol; 2020 Jul; 21(7):888. PubMed ID: 32563279
    [No Abstract]   [Full Text] [Related]  

  • 13. Host-microbe cross talk in cancer therapy.
    Vanhoecke B; Stringer A
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):174-81. PubMed ID: 25872117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Microbiome and Its Potential for Pharmacology.
    Chavira A; Belda-Ferre P; Kosciolek T; Ali F; Dorrestein PC; Knight R
    Handb Exp Pharmacol; 2019; 260():301-326. PubMed ID: 31820171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet, Microbiome, and Epigenetics in the Era of Precision Medicine.
    Riscuta G; Xi D; Pierre-Victor D; Starke-Reed P; Khalsa J; Duffy L
    Methods Mol Biol; 2018; 1856():141-156. PubMed ID: 30178250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial endocrinology: the interplay between the microbiota and the endocrine system.
    Neuman H; Debelius JW; Knight R; Koren O
    FEMS Microbiol Rev; 2015 Jul; 39(4):509-21. PubMed ID: 25701044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the Microbiome to Enhance Cancer Immunotherapy.
    Nelson MH; Diven MA; Huff LW; Paulos CM
    J Immunol Res; 2015; 2015():368736. PubMed ID: 26101781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Microbiome in Immuno-oncology.
    Toker J; Arora R; Wargo JA
    Adv Exp Med Biol; 2020; 1244():325-334. PubMed ID: 32301026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome and Anticancer Immunosurveillance.
    Zitvogel L; Ayyoub M; Routy B; Kroemer G
    Cell; 2016 Apr; 165(2):276-87. PubMed ID: 27058662
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Hernandez-Sanabria E; Slomka V; Herrero ER; Kerckhof FM; Zaidel L; Teughels W; Boon N
    Front Cell Infect Microbiol; 2017; 7():235. PubMed ID: 28638806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.